Capecitabine as a Radiosensitizer in Adjuvant Chemoradiotherapy for Pancreatic Cancer: A Retrospective Study Academic Article uri icon

Overview

MeSH Major

  • Capecitabine
  • Pancreatic Neoplasms
  • Radiation-Sensitizing Agents

abstract

  • Concurrent chemoradiation using capecitabine as a radiosensitizer in the adjuvant setting for pancreatic cancer was completed by the vast majority of patients in this series. Treatment was relatively well-tolerated, and its efficacy seems comparable to that for historical controls. This study probably represents the largest yet reported using capecitabine in this setting. Future studies including an increased sample size are required.

publication date

  • December 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 26637914

Additional Document Info

start page

  • 6901

end page

  • 7

volume

  • 35

number

  • 12